日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase I clinical trial of mixed bacterial vaccine (Coley's toxins) in patients with NY-ESO-1 expressing cancers: immunological effects and clinical activity

混合细菌疫苗(科利毒素)对 NY-ESO-1 表达癌症患者的 I 期临床试验:免疫学效果和临床活性

Julia Karbach, Antje Neumann, Kathrin Brand, Claudia Wahle, Ekkehard Siegel, Markus Maeurer, Erika Ritter, Takamasa Tsuji, Sacha Gnjatic, Lloyd J Old, Gerd Ritter, Elke Jäger

Isoform specific anti-TGFβ therapy enhances antitumor efficacy in mouse models of cancer

异构体特异性抗 TGFβ 疗法增强小鼠癌症模型的抗肿瘤功效

Aditi Gupta, Sadna Budhu, Kelly Fitzgerald, Rachel Giese, Adam O Michel, Aliya Holland, Luis Felipe Campesato, Jacques van Snick, Catherine Uyttenhove, Gerd Ritter, Jedd D Wolchok, Taha Merghoub

Toxicological and pharmacological assessment of AGEN1884, a novel human IgG1 anti-CTLA-4 antibody

新型人 IgG1 抗 CTLA-4 抗体 AGEN1884 的毒理学和药理学评估

Randi B Gombos, Ana Gonzalez, Mariana Manrique, Dhan Chand, David Savitsky, Benjamin Morin, Ekaterina Breous-Nystrom, Christopher Dupont, Rebecca A Ward, Cornelia Mundt, Benjamin Duckless, Hao Tang, Mark A Findeis, Andrea Schuster, Jeremy D Waight, Dennis Underwood, Christopher Clarke, Gerd Ritter, 

Blockade of CTLA-4 promotes the development of effector CD8+ T lymphocytes and the therapeutic effect of vaccination with an attenuated protozoan expressing NY-ESO-1

CTLA-4 阻断促进效应 CD8+ T 淋巴细胞的发育以及用表达 NY-ESO-1 的减毒原生动物接种疫苗的治疗效果

Luara Isabela Dos Santos, Bruno Galvão-Filho, Paula Cristina de Faria, Caroline Junqueira, Miriam Santos Dutra, Santuza Maria Ribeiro Teixeira, Maurício Martins Rodrigues, Gerd Ritter, Oliver Bannard, Douglas Thomas Fearon, Lis Ribeiro Antonelli, Ricardo Tostes Gazzinelli

Overcoming regulatory T-cell suppression by a lyophilized preparation of Streptococcus pyogenes

利用化脓性链球菌冻干制剂克服调节性 T 细胞抑制

Michiko Hirayama, Hiroyoshi Nishikawa, Yasuhiro Nagata, Takemasa Tsuji, Takuma Kato, Shinichi Kageyama, Shugo Ueda, Daisuke Sugiyama, Sahoko Hori, Shimon Sakaguchi, Gerd Ritter, Lloyd J Old, Sacha Gnjatic, Hiroshi Shiku

Rebmab200, a humanized monoclonal antibody targeting the sodium phosphate transporter NaPi2b displays strong immune mediated cytotoxicity against cancer: a novel reagent for targeted antibody therapy of cancer

Rebmab200 是一种靶向磷酸钠转运体 NaPi2b 的人源化单克隆抗体,具有强大的免疫介导抗癌细胞毒性:一种用于癌症靶向抗体治疗的新型试剂

Mariana Lopes dos Santos, Fernanda Perez Yeda, Lilian Rumi Tsuruta, Bruno Brasil Horta, Alécio A Pimenta Jr, Theri Leica Degaki, Ibere C Soares, Maria Carolina Tuma, Oswaldo Keith Okamoto, Venancio A F Alves, Lloyd J Old, Gerd Ritter, Ana Maria Moro

Trypanosoma cruzi adjuvants potentiate T cell-mediated immunity induced by a NY-ESO-1 based antitumor vaccine

克氏锥虫佐剂增强 NY-ESO-1 抗肿瘤疫苗诱导的 T 细胞介导免疫

Caroline Junqueira, Ana Tereza Guerrero, Bruno Galvão-Filho, Warrison A Andrade, Ana Paula C Salgado, Thiago M Cunha, Catherine Ropert, Marco Antônio Campos, Marcus L O Penido, Lúcia Mendonça-Previato, José Oswaldo Previato, Gerd Ritter, Fernando Q Cunha, Ricardo T Gazzinelli

(124)I-huA33 antibody PET of colorectal cancer

(124)I-huA33抗体结直肠癌PET

Jorge A Carrasquillo, Neeta Pandit-Taskar, Joseph A O'Donoghue, John L Humm, Pat Zanzonico, Peter M Smith-Jones, Chaitanya R Divgi, Daniel A Pryma, Shutian Ruan, Nancy E Kemeny, Yuman Fong, Douglas Wong, Jaspreet S Jaggi, David A Scheinberg, Mithat Gonen, Katherine S Panageas, Gerd Ritter, Achim A J

Split T cell tolerance against a self/tumor antigen: spontaneous CD4+ but not CD8+ T cell responses against p53 in cancer patients and healthy donors

针对自身/肿瘤抗原的分裂 T 细胞耐受性:癌症患者和健康供体中针对 p53 的自发 CD4+ T 细胞应答,而非 CD8+ T 细胞应答

Takemasa Tsuji, Junko Matsuzaki, Erika Ritter, Anthony Miliotto, Gerd Ritter, Kunle Odunsi, Lloyd J Old, Sacha Gnjatic

NY-ESO-1 DNA vaccine induces T-cell responses that are suppressed by regulatory T cells

NY-ESO-1 DNA 疫苗诱导的 T 细胞反应受到调节性 T 细胞的抑制

Sacha Gnjatic, Nasser K Altorki, Derek Ng Tang, Shi-Ming Tu, Vikas Kundra, Gerd Ritter, Lloyd J Old, Christopher J Logothetis, Padmanee Sharma